Evidence map›Paper›PMID 37449204›Full record

ArticleFrontiers in immunology2023

Identification of biomarkers related to sepsis diagnosis based on bioinformatics and machine learning and experimental verification.

Qianfei Wang, Chenxi Wang, Weichao Zhang, Yulei Tao, Junli Guo, Yuan Liu, Zhiliang Liu, Dong Liu, Jianqiang Mei, Fenqiao Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Qianfei WangHebei University of Chinese Medicine, Shijiazhuang, China.
Chenxi WangHebei University of Chinese Medicine, Shijiazhuang, China.
Weichao ZhangHebei University of Chinese Medicine, Shijiazhuang, China.
Yulei TaoHebei University of Chinese Medicine, Shijiazhuang, China.
Junli GuoHebei University of Chinese Medicine, Shijiazhuang, China.
Yuan LiuHebei University of Chinese Medicine, Shijiazhuang, China.
Zhiliang LiuHebei University of Chinese Medicine, Shijiazhuang, China.
Dong LiuHebei University of Chinese Medicine, Shijiazhuang, China.
Jianqiang MeiThe First Affiliated Hospital ,Hebei University of Chinese Medicine, Shijiazhuang, China.
Fenqiao ChenThe First Affiliated Hospital ,Hebei University of Chinese Medicine, Shijiazhuang, China.
Hebei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a systemic inflammatory response syndrome caused by bacteria and other pathogenic microorganisms. Every year, approximately 31.5 million patients are diagnosed with sepsis, and approximately 5.3 million patients succumb to the disease. In this study, we identified biomarkers for diagnosing sepsis analyzed the relationships between genes and Immune cells that were differentially expressed in specimens from patients with sepsis compared to normal controls. Finally, We verified its effectiveness through animal experiments. Specifically, we analyzed datasets from four microarrays(GSE11755、GSE12624、GSE28750、GSE48080) that included 106 blood specimens from patients with sepsis and 69 normal human blood samples. SVM-RFE analysis and LASSO regression model were carried out to screen possible markers. The composition of 22 immune cell components in patients with sepsis were also determined using CIBERSORT. The expression level of the biomarkers in Sepsis was examined by the use of qRT-PCR and Western Blot (WB). We identified 50 differentially expressed genes between the cohorts, including 2 significantly upregulated and 48 significantly downregulated genes, and KEGG pathway analysis identified Salmonella infection, human T cell leukemia virus 1 infection, Epstein-Barr virus infection, hepatitis B, lysosome and other pathways that were significantly enriched in blood from patients with sepsis. Ultimately, we identified COMMD9, CSF3R, and NUB1 as genes that could potentially be used as biomarkers to predict sepsis, which we confirmed by ROC analysis. Further, we identified a correlation between the expression of these three genes and immune infiltrate composition. Immune cell infiltration analysis revealed that COMMD9 was correlated with T cells regulatory (Tregs), T cells follicular helper, T cells CD8, et al. CSF3R was correlated with T cells regulatory (Tregs), T cells follicular helper, T cells CD8, et al. NUB1 was correlated with T cells regulatory (Tregs), T cells gamma delta, T cells follicular helper, et al. Taken together, our findings identify potential new diagnostic markers for sepsis that shed light on novel mechanisms of disease pathogenesis and, therefore, may offer opportunities for therapeutic intervention.

Indexed as

Epstein-Barr Virus InfectionsSepsisAdaptor Proteins, Signal TransducingAnimalsBiomarkersComputational BiologyHerpesvirus 4, HumanHumansMachine LearningAdaptor Proteins, Signal TransducingBiomarkersNUB1 protein, humangeneimmune infiltrationpathwaysRNAsepsis

Identifiers

PMID37449204
PMCPMC10337583
OpenAlexW4382585312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.